TORVANTA
Other · S&P 500 · data as of 2026-10-05

VCYT stock analysis: VCYT

VCYT (VCYT) is an S&P 500 company in Other. It grades strongest on growth and weakest on value.

The model's view of VCYT · subscribers

Where VCYT ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with VCYT · updated 2026-10-05 · from prices and SEC filings

VCYT price performance

VCYT against the S&P 500, one year
+0%+50%VCYT +42%S&P 500 +18%2025-09-292026-10-05
Year to date+13.2%S&P 500 +14.5% · behind by 1.3 pts
1 year+32.4%S&P 500 +17.0% · ahead by 15.4 pts
3 years+123.3%S&P 500 +89.3% · ahead by 34.0 pts
5 years+7.5%S&P 500 +91.3% · behind by 83.8 pts

Total returns with dividends reinvested.

VCYT factor grades

Each grade compares VCYT with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

C-ValueP/E 34.0x (industry 20.1x)FCF yield 4.3% (industry 6.0%)
AGrowthRevenue growth +17% (industry +8%)EPS growth +324% (industry +10%)
BProfitabilityOperating margin 18.8% (industry 9.6%)ROIC 9.6% (industry 10.1%)
CMomentum12-month change +32%From 52-wk high -21%

VCYT in plain numbers

VCYT key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$3.8B
Revenue growth (y/y)+17%
Free-cash-flow yield4.3%
Dividend yieldn/a
Next earnings (expected)2026-11-03
Valuation measures
Market value$3.8B
Enterprise value$3.5B
P/E (trailing)34.0x
Forward P/E (Torvanta estimate)22.7x
PEG (Torvanta estimate)0.45
Price / sales6.8x
Price / book2.8x
EV / revenue6.3x
EV / EBITDA27.9x
Financial highlights
Revenue, last 12 months$561.9M
Net income, last 12 months$114.5M
EPS, last 12 months (GAAP)$1.40
Gross margin71.7%
Operating margin18.8%
Net margin20.4%
Return on equity8.8%
Return on invested capital9.6%
Cash$299.5M
Free cash flow, last 12 months$166.0M
Current ratio9.16x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

VCYT earnings trends

Revenue vs earnings
-$1.0M$36.8M$74.7M$112.5M$150.3MSep 2024 Revenue: $115.9MDec 2024 Revenue: $118.6MMar 2025 Revenue: $114.5MJun 2025 Revenue: $130.2MSep 2025 Revenue: $131.9MDec 2025 Revenue: $140.6MMar 2026 Revenue: $139.1MJun 2026 Revenue: $150.3MSep 2024 Net income: $15.2MDec 2024 Net income: $5.1MMar 2025 Net income: $7.0MJun 2025 Net income: -$1.0MSep 2025 Net income: $19.1MDec 2025 Net income: $41.1MMar 2026 Net income: $28.7MJun 2026 Net income: $25.5MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: 13.1%Net margin: 4.3%Net margin: 6.2%Net margin: -0.8%Net margin: 14.5%Net margin: 29.3%Net margin: 20.6%Net margin: 17.0%-1%14%29%■ Revenue ■ Net income ━ Net margin
Earnings per share$-0.0$0.1$0.2$0.4$0.5Sep 2024 EPS (GAAP, diluted): $0.2Dec 2024 EPS (GAAP, diluted): $0.1Mar 2025 EPS (GAAP, diluted): $0.1Jun 2025 EPS (GAAP, diluted): $-0.0Sep 2025 EPS (GAAP, diluted): $0.2Dec 2025 EPS (GAAP, diluted): $0.5Mar 2026 EPS (GAAP, diluted): $0.4Jun 2026 EPS (GAAP, diluted): $0.3Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Sep 2025 +26% · Dec 2025 +733% · Mar 2026 +289%

From the company's 10-Q and 10-K filings with the SEC.

VCYT financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$219.5M$296.5M$361.1M$445.8M$517.1M
Net income-$75.6M-$36.6M-$74.4M$24.1M$66.4M
EPS (GAAP)$-1.13$-0.50$-1.02$0.30$0.82
Free cash flow-$37.0M-$1.0M$34.3M$63.8M$126.6M

VCYT earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-07-30$0.31n/a+15%-19.3%
2026-05-05$0.35+289%+21%+20.9%
2026-02-25$0.50+733%+19%+8.3%
2026-01-12$0.50+733%+19%+2.4%
2025-11-04$0.24+26%+14%+27.2%
2025-08-06$-0.01-114%+14%+10.0%

About VCYT

HeadquartersSouth San Francisco, CA
Industry (SEC code)Services-Medical Laboratories
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq
FormerlyCALDEROME INC

From the company's SEC registration record.

Companies similar to VCYT

CompanyMarket valueP/ERevenue growthOperating margin12-month change
VCYT VCYT$3.8B34.0x+17%18.8%+32%
CRK CRK$3.8B7.3x+32%28.8%-39%compare
CRVL CRVL$3.8B33.8x+7%n/a+3%compare
ITRI ITRI$3.8B14.7x-6%13.2%-30%compare
AVNT AVNT$3.8B22.5x+2%9.5%+31%
CAR CAR$3.8Bn/a+1%n/a-30%
FCN FCN$3.8B16.6x+7%9.7%-14%

All Other stock ratings

Frequently asked questions

Is VCYT stock a buy?

Torvanta does not tell individuals what to buy. Its grades for VCYT are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

What is VCYT's P/E ratio?

VCYT trades at about 34.1 times its last 12 months of GAAP earnings reported to the SEC, and about 22.7 times Torvanta's own estimate of the next 12 months.

When does VCYT report earnings next?

Based on its filing history, Torvanta expects VCYT to report around 2026-11-03.

How has VCYT performed against the S&P 500?

Over the past year VCYT returned +32.4%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer